1. Zhang, Qifan, Zhang, Yunbin, Sun, Shibo, Tao, Tao, Zhou, Jie. 2021. ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway. In Cell death & disease, 12, 15. doi:10.1038/s41419-020-03291-2. https://pubmed.ncbi.nlm.nih.gov/33414412/
2. Chen, Jiandi, Chen, Jianxu, Fu, Huirong, Luo, Shunkui, Lu, Hongyun. 2019. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway. In American journal of physiology. Endocrinology and metabolism, 317, E710-E722. doi:10.1152/ajpendo.00052.2019. https://pubmed.ncbi.nlm.nih.gov/31430204/
3. Tan, Zeheng, Deng, Yulin, Cai, Zhiduan, Zhong, Weide, Guo, Kai. 2024. ACOX2 Serves as a Favorable Indicator Related to Lipid Metabolism and Oxidative Stress for Biochemical Recurrence in Prostate Cancer. In Journal of Cancer, 15, 3010-3023. doi:10.7150/jca.93832. https://pubmed.ncbi.nlm.nih.gov/38706909/
4. Sui, Jane S Y, Martin, Petra, Keogh, Anna, Young, Vincent, Gray, Steven G. 2022. Altered expression of ACOX2 in non-small cell lung cancer. In BMC pulmonary medicine, 22, 321. doi:10.1186/s12890-022-02115-7. https://pubmed.ncbi.nlm.nih.gov/35999530/
5. Du, Xianglin, Ma, Zhen, Xing, Yanqing, Huo, Rujie, Tian, Xinrui. 2024. Identification and validation of potential biomarkers related to oxidative stress in idiopathic pulmonary fibrosis. In Immunobiology, 229, 152791. doi:10.1016/j.imbio.2024.152791. https://pubmed.ncbi.nlm.nih.gov/39180853/
智鼠故事 
